Zemplar

Active Ingredient(s): Paricalcitol
FDA Approved: * April 17, 1998
Pharm Company: * ABBOTT
Category: Thyroid

Paricalcitol (chemically it is 19-nor-1,25-(OH)2-vitamin D2. Marketed by Abbott Laboratories under the trade name Zemplar) is a drug used for the prevention and treatment of secondary hyperparathyroidism (excessive secretion of parathyroid hormone) associated with chronic kidney failure. It is an analog of 1,25-dihydroxyergocalciferol, the active form of vitamin D2 (ergocalciferol). It was patented in 1989 and approved for medical use in 1998.[2] Contents 1 Medical uses 2 Ad... [wikipedia]

* May have multiple approval dates, manufacturers, or labelers.
2 Discussions

Dosage List

Zemplar A;ZF
Zemplar 0.002 mg Oral Capsule
NDC: 0074-4314
Labeler:
Abbvie Inc.
Zemplar A;ZK
Zemplar 0.004 mg Oral Capsule
NDC: 0074-4315
Labeler:
Abbvie Inc.
Zemplar A;ZA
Zemplar 0.001 mg Oral Capsule
NDC: 0074-4317
Labeler:
Abbvie Inc.
Zemplar 5 ug/ml Intravenous Injection, Solution
NDC: 0074-1658
Labeler:
Abbvie Inc.
Zemplar 2 ug/ml Intravenous Injection, Solution
NDC: 0074-4637
Labeler:
Abbvie Inc.
Zemplar 1 ug/1 Oral Capsule, Liquid Filled
NDC: 0074-9036
Labeler:
Abbvie Inc.
Zemplar 2 ug/1 Oral Capsule, Liquid Filled
NDC: 0074-9037
Labeler:
Abbvie Inc.
Zemplar 0.001 mg Oral Capsule
NDC: 55154-6971
Labeler:
Cardinal Health

Popular Topics

side effects of zemplar

renal Failure...